Results 11 to 20 of about 48,070 (253)

Digoxin and Amiodarone on the Risk of Ischemic Stroke in Atrial Fibrillation: An Observational Study

open access: yesFrontiers in Pharmacology, 2018
Purpose: The present study compared the risk of ischemic stroke in atrial fibrillation (AF) patients receiving digoxin and amiodarone.Methods: A retrospective cohort study was conducted using the longitudinal population-based database of Taiwan’s ...
Kuan-Cheng Lai   +13 more
doaj   +2 more sources

Digoxin Alleviates Osteoarthritis by Inhibiting Macrophage Extracellular Trap Formation via Disruption of the LSP1-SOD1 Interaction. [PDF]

open access: yesAdv Sci (Weinh)
Synovial macrophages in osteoarthritis upregulate LSP1, which directly binds and inhibits SOD1, triggering a redox imbalance that activates both NOX and mitochondrial ROS pathways. This cascade drives the release of macrophage extracellular traps (METs), causing chondrocyte damage and disease progression.
Pan Y   +9 more
europepmc   +2 more sources

Digoxin is a potent inhibitor of Bunyamwera virus infection in cell culture [PDF]

open access: yes, 2023
Drug repurposing is a valuable source of new antivirals because many compounds used to treat a variety of pathologies can also inhibit viral infections.
Pacheco González, Beatriz   +10 more
core   +1 more source

Digoxin Intoxication [PDF]

open access: yes, 2022
Digoxin is a cardiac glycoside used in the treatment of heart failure and arrhythmia. It has a positive effect on ventricular contraction. However, it causes a decrease in heart rate due to its negative effect on the atrioventricular (AV) node.
Küçük, Uğur   +3 more
core   +1 more source

‘Digoxin conundrum – Time for validation?’

open access: yesIndian Heart Journal, 2021
Despite no incontrovertible data, Digoxin use has been demonised. As a consequence, a lot of patients, stable on Digoxin, have been taken off it and offered alternative drugs.
O.P. Yadava
doaj   +1 more source

Clinical Pharmacology in Transgender Medicine: What Gaps Remain? [PDF]

open access: yesClin Pharmacol Ther
Mechanistic information is limited about the effects of gender‐affirming hormone therapy and the unique factors that influence the absorption, distribution, metabolism, and excretion properties of medications across therapeutic classes for transgender people.
Cirrincione LR.
europepmc   +2 more sources

Case report on the interaction between furosemide and digoxin that caused digoxin toxicity [PDF]

open access: yes, 2022
Toxicity from digitalis is a typical clinical issue. In this case, the interaction of digoxin and furosemide is becoming more widely recognised as a major cause of digitalis toxicity.
Patel, Nisarg   +4 more
core   +1 more source

Review: Failure of current digoxin monitoring for toxicity: new monitoring recommendations to maintain therapeutic levels for efficacy

open access: yesFrontiers in Cardiovascular Medicine, 2023
The current recommendations for monitoring digoxin, a narrow therapeutic index drug, are limited to confirming medication use or investigating suspicion of toxicity and fail our oath to do no harm.
Sridhar Rao Gona   +5 more
doaj   +1 more source

Clinical signs and symptoms of toxic serum digoxin levels in neonates

open access: yesThe Turkish Journal of Pediatrics, 2019
Digoxin is widely used in the treatment of congestive heart failure and some arrhythmias. Digoxin toxicity may occur easily because digoxin has a narrow therapeutic index.
Mehmet Mutlu   +4 more
doaj   +1 more source

Interaction between Chinese medicine and digoxin: Clinical and research update

open access: yesFrontiers in Pharmacology, 2023
Background: Digoxin is one of the most widely and commonly used cardiac drug, which plays an irreplaceable role in treating heart failure and arrhythmia.
Wei Zhuang   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy